Drug Profile
TY 51501
Latest Information Update: 31 Jan 2008
Price :
$50
*
At a glance
- Originator Toa Eiyo
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus
Most Recent Events
- 16 Jun 2004 Data presented at the 64th Scientific Sessions of the American Diabetes Association (ADA-2004) have been added to the Diabetes pharmacodynamics section
- 31 Oct 2003 TY 51501 is available for licensing (http://www.toaeiyo.co.jp)
- 27 Jun 2003 Preclinical trials in Type-2 diabetes mellitus in Japan (PO)